AI-powered market analysis and insights

While everyone fights over Nvidia and the Mag Seven, these three small-caps are quietly building cases for a breakout. Nobody's watching. That's the point.

French 10-year yields near 5%, spreads over German bunds at 2011 wides, and not a budget balanced since 1974. Sleep tight.

Chipotle surged 6% on merger buzz while Starbucks slid 2.5%. The deal would shatter restaurant M&A records, but does the math actually work?

Hormuz tanker attacks just hit their worst week since the Iran war began. Oil is jumping. The VIX is at 15. The market is fine, apparently.

The Hormuz crisis is pumping oil headlines AND crypto Twitter. Here's which corners of the altcoin market are catching fire right now.

Earnings season is officially open. The S&P 500 is flirting with record highs, VIX is asleep, and retail traders are loudly disagreeing about whether AI stocks can back up the hype.

Forget the mega-caps. Three small-cap names with real catalysts are flying under the radar while Wall Street obsesses over AI narratives.

This week's stock movers told a brutal story: one industrial software name had its best week since 2000, while two chip names got absolutely humbled.

Moderna spiked 14% and Novavax jumped 16% on reports of a fast-tracked cancer vaccine program. Biotech just crashed the AI party.

Bitcoin is knocking on $100K while Ethereum sentiment just surged 40%. Here's what the social data actually says about where this goes next.

Humana just went from healthcare's ugly duckling to its golden child overnight. Here's why the Medicare star rating flip is a much bigger deal than it looks.

SpaceX just dropped $8B on spectrum licenses and suddenly AT&T, Verizon, and T-Mobile look like Blockbuster employees watching Netflix sign a lease next door.